5 rezultati
PRIORITY
This application is a national phase filing of the Patent Cooperation Treaty (PCT) application # PCT/IB2013/052328 titled "PRODRUGS OF ANTI-PLATELET AGENTS" filed on Mar. 24, 2013 Published with WIPO Publication # WO/2013/168024, which further claims priority to Patent Cooperation Treaty
FIELD OF THE INVENTION
This invention relates to medical science particularly the treatment of thrombotic disorders with activated human protein C in combination with antiplatelet agents.
BACKGROUND OF THE INVENTION
Protein C is a serine protease and naturally occurring anticoagulant that plays a
BACKGROUND OF THE INVENTION
Platelet activation and aggregation are involved in unstable angina and acute myocardial infarction, in reocclusion following thrombolytic therapy and angioplasty, in transient ischemic attacks and in a variety of other vaso-occlusive disorders. When a blood vessel is
BACKGROUND OF THE INVENTION
Platelet activation and aggregation are involved in unstable angina and acute myocardial infarction, in reocclusion following thrombolytic therapy and angioplasty, in transient ischemic attacks and in a variety of other vaso-occlusive disorders. When a blood vessel is
TECHNICAL FIELD
The presently-disclosed subject matter relates to diagnosis, prognosis and treatment associated with a cardiovascular event. In particular, the presently-disclosed subject matter methods of providing anti-platelet therapy, and methods of diagnosis, prognosis, and treatment associated